NASDAQ:HTGM

HTG Molecular Diagnostics, Inc Earning Date

USA |NASDAQ |USD

HTGM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.70 $-0.65 $-1.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $2.58M $2.07M $1.78M

Htg Molecular Diagnostics, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

HTGM Earnings Date & History Chart

HTGM Earnings & Revenue Forecast

HTGM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.57 $-0.78 $-0.41
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-2.54 $-2.75 $-2.25
Dec 2022 4 $-2.00 $-2.54 $-1.68

HTGM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.57 $-0.61 $-0.61
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.54 $-2.85 $-2.92
Dec 2022 0 / 0 $-2.00 $-2.31 $-2.33

HTGM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $2.90M $2.70M $3.01M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $8.99M $8.50M $9.50M
Dec 2022 4 $17.21M $13.50M $22.00M

HTGM Earnings Date & Revenue History

HTGM Earnings History

|
Show More
Show More

HTGM Revenue History

|
Show More
Show More

Htg Molecular Diagnostics, Inc Next Earnings Date & Report

HTGM Next Earnings Date & Report Preview: Sep 2021 (FQ)

HTGM's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Htg Molecular Diagnostics, Inc's next quarterly earnings is $-0.70, with a low EPS estimation of $-0.78, and a high estimation of $-0.56.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.70, the last 2 month trend is $-0.74, and the 3 month trend is $-0.75.

Based on 3 analysts, the average revenue estimation is $2.58M, with a low revenue estimation of $2.30M, and a high estimation of $3.00M.

Htg Molecular Diagnostics, Inc Previous Earnings Dates & Reports

HTGM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Htg Molecular Diagnostics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

HTGM's earnings per share (EPS) was $-0.65, beating the consensus analysts forecast of $-0.77 by 15.23%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -18.68%, and higher than the same period a year before (Jun 2020) by -45.03%.

Revenues were $2.07M, better than the forecast of $2.07M by 0.01%, up by 44.53% from the previous quarter , and up by 5.65% from the same period last year.

The company reported a net income of $-2.61M.

Free cash flow for the quarter was $-4.69M , compared to $-4.45M last quarter and $-4.75M a year before.

HTGM ended the quarter with $10.89M in total debt, a decrease of -8.81% compared to the previous quarter, and a decrease of -2.71% compared to the same quarter a year before.

HTGM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Htg Molecular Diagnostics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

HTGM's earnings per share (EPS) was $-4.34, beating the consensus analysts forecast of $-4.80 by -9.51% , and higher than the previous year's EPS (Dec 2019) by -44.31%.

Revenues were $8.55M, better than the forecast of $8.25M by 3.62%, and down by -55.48% from previous year's revenue.

The company reported a net income of $-20.87M.

Htg Molecular Diagnostics, Inc reported a free cash flow of $-16.75M for its fiscal year, compared to $-17.80M a year ago.

The company ended the fiscal year with $12.28M in total debt, an increase of 15.61% compared to the previous year.